A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
To compare the rate and extent of absorption of carvedilol from a test formulation of
Carvedilol 12.5 mg Tablets versus the reference Coreg® 12.5 mg Tablets under fasting
conditions.